晨报讯（记者 徐晶晶）昨日记者获悉，手足口疫苗三期临床试验结果揭晓，疫苗可使疾病保护率达到95%。这也就意味着，一旦上市，长期困扰患儿和家长的手足口疾病将得到有效防控。

Morning news(The reporter Xu Jingjing)Yesterday, reporters learned that,Three periods of FMD vaccine clinical trials,Vaccines can make the disease protection ratio reached 95%.This means,Once the listed,Has long vexed, foot and mouth disease children and their parents will get effective control and prevention.

　　据介绍，这种EV71 疫苗III期临床研究从去年1月6日正式启动，先后对1万余名婴幼儿进行了疫苗接种，完成了长达一年的流行病学保护效果观察。结果显示，连续三批 EV71 疫苗均能在6个月至5岁人群产生良好的免疫，并具有较好的安全性。手足口病是一种婴幼儿常见的传染病，夏季为手足口病发病高峰。因为幼儿园经常发生疫情，该疫苗需要打两针，6岁以下都要打。该疫苗有望于今年下半年获批上市。不过目前尚未研究是否纳入计划免疫，上市后其价格将参考二类疫苗价格定价。

According to introducing,This kind of EV71 vaccine in phase III clinical study last year launched on January 6,Successively has carried on the vaccine to 10000 infants and young children,Completed a year-long epidemiological protection effect is observed.According to the results,For three consecutive batch of EV71 vaccine can in 6 months to 5 years old people to produce good immune,And has good security.Hand, foot and mouth disease is a common infectious disease in infants,Summer for hand, foot and mouth disease outbreak.Because the kindergarten often occurred,The vaccine requires two injection,Under 6 years of age to play.The vaccine is expected to be listed in the second half of the year is approved.But has yet to study whether or not incorporated in the immunization,After the price will be priced reference price of 2 kinds of vaccines.